Postprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans
Postprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans
Eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are important components of cell membranes. Since humans have limited ability for EPA and DHA synthesis, these must be obtained from the diet, primarily from oily fish. Dietary EPA and DHA intakes are constrained by the size of fish stocks and by food choice. Seed oil from transgenic plants that synthesise EPA and DHA represents a potential alternative source of these fatty acids, but this has not been tested in humans. We hypothesised that incorporation of EPA and DHA into blood lipids from transgenic Camelina sativa seed oil (CSO) is equivalent to that from fish oil. Healthy men and women (18 to 30 years or 50 to 65 years) consumed 450 mg EPA plus DHA from either CSO or commercial blended fish oil (BFO) in test meals in a double blind, postprandial cross-over trial. There were no significant differences between test oils or sexes in EPA and DHA incorporation into plasma triacylglycerol, phosphatidylcholine or non-esterified fatty acids over 8 hours. There were no significant differences between test oils, age groups or sexes in postprandial VLDL, LDL or HDL sizes or concentrations. There were no significant differences between test oils in postprandial plasma TNFα, interleukin 6 or 10, or soluble intercellular cell adhesion molecule-1 concentrations in younger participants. These findings show that incorporation into blood lipids of EPA and DHA consumed as CSO was equivalent to BFO and that such transgenic plant oils are a suitable dietary source of EPA and DHA in humans.
1235-1246
West, Annette
c1923242-802f-4331-b743-31de45d3883c
Miles, Elizabeth
20332899-ecdb-4214-95bc-922dde36d416
Lillycrop, Karen
eeaaa78d-0c4d-4033-a178-60ce7345a2cc
Han, Lilua
84538a07-a7ac-46ad-b018-a584181ec1fd
Sayanova, Olga
94cdbfaa-cc3a-4216-bae7-56a17dd8b3f4
Napier, Johnathan
b3c688c3-f270-4ebb-b9a7-250011c8a960
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Burdge, Graham
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
1 June 2019
West, Annette
c1923242-802f-4331-b743-31de45d3883c
Miles, Elizabeth
20332899-ecdb-4214-95bc-922dde36d416
Lillycrop, Karen
eeaaa78d-0c4d-4033-a178-60ce7345a2cc
Han, Lilua
84538a07-a7ac-46ad-b018-a584181ec1fd
Sayanova, Olga
94cdbfaa-cc3a-4216-bae7-56a17dd8b3f4
Napier, Johnathan
b3c688c3-f270-4ebb-b9a7-250011c8a960
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Burdge, Graham
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
West, Annette, Miles, Elizabeth, Lillycrop, Karen, Han, Lilua, Sayanova, Olga, Napier, Johnathan, Calder, Philip and Burdge, Graham
(2019)
Postprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans.
British Journal of Nutrition, 121 (1), .
(doi:10.1017/S0007114519000825).
Abstract
Eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are important components of cell membranes. Since humans have limited ability for EPA and DHA synthesis, these must be obtained from the diet, primarily from oily fish. Dietary EPA and DHA intakes are constrained by the size of fish stocks and by food choice. Seed oil from transgenic plants that synthesise EPA and DHA represents a potential alternative source of these fatty acids, but this has not been tested in humans. We hypothesised that incorporation of EPA and DHA into blood lipids from transgenic Camelina sativa seed oil (CSO) is equivalent to that from fish oil. Healthy men and women (18 to 30 years or 50 to 65 years) consumed 450 mg EPA plus DHA from either CSO or commercial blended fish oil (BFO) in test meals in a double blind, postprandial cross-over trial. There were no significant differences between test oils or sexes in EPA and DHA incorporation into plasma triacylglycerol, phosphatidylcholine or non-esterified fatty acids over 8 hours. There were no significant differences between test oils, age groups or sexes in postprandial VLDL, LDL or HDL sizes or concentrations. There were no significant differences between test oils in postprandial plasma TNFα, interleukin 6 or 10, or soluble intercellular cell adhesion molecule-1 concentrations in younger participants. These findings show that incorporation into blood lipids of EPA and DHA consumed as CSO was equivalent to BFO and that such transgenic plant oils are a suitable dietary source of EPA and DHA in humans.
Text
Postprandial paper Accepted Version
- Accepted Manuscript
More information
Accepted/In Press date: 27 March 2019
e-pub ahead of print date: 12 April 2019
Published date: 1 June 2019
Identifiers
Local EPrints ID: 429720
URI: http://eprints.soton.ac.uk/id/eprint/429720
ISSN: 0007-1145
PURE UUID: cafb5ced-6582-4323-b60a-e7706a4203c6
Catalogue record
Date deposited: 04 Apr 2019 16:30
Last modified: 16 Mar 2024 03:43
Export record
Altmetrics
Contributors
Author:
Annette West
Author:
Lilua Han
Author:
Olga Sayanova
Author:
Johnathan Napier
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics